Toxic effects of repeated oral exposure of silver nanoparticles on small intestine mucosa of mice

Toxicology Mechanisms and Methods

Volumn 23, Issue 3, 2013, Pages 161-167

  Shahare, Brigesh ^a,b   Yashpal, Madhu ^a   Singh, Gajendra ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b G R MEDICAL COLLEGE   (India)

Author keywords

Microvilli; Mitotic figure; Silver nanoparticles; Transmission electron microscope

Indexed keywords

SILVER NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; EPITHELIUM CELL; EXPOSURE; MALE; MICROVILLUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE MUCOSA; TOXICITY; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, ORAL; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; EPITHELIAL CELLS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; METAL NANOPARTICLES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROVILLI; SILVER NITRATE; TIME FACTORS; WEIGHT LOSS;

ANIMALIA; MUS;

EID: 84879588654     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2013.764950     Document Type: Article

References (31)

1. Alt V, Bechert T, Steinrucke P, et al. (2004). An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 25:4383-91.
2. Bouin P. (1897). Phenomenes Cytologique anoramaux dans. I'Histogenes, Nancy.
3. Castellano JJ, Shafii SM, Ko F, et al. (2007). Comparative evaluation of silver-containing antimicrobial dressings and drugs. Int wound J 4:114-22.
4. Errington RJ, Brown MR, Silvestre OF, et al. (2010). Single cell nanoparticle tracking to model cell cycle dynamics and compartmental inheritance. Cell Cycle 9:121-30.
5. Florence AT. (1997). The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharmaceut Res 14:259-66.
6. Florence AT, Hussain N. (2001). Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. Adv Drug Deliv Rev 50:S69-89.
7. Huang Z, Jiang X, Guo D, Gu N. (2011). Controllable synthesis and biomedical applications of silver nanomaterials. J Nanosci Nanotechnol 11:9395-408.
8. Hussain N, Jaitley V, Florence AT. (2001). Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev 50:107-42.
9. Jeong GN, Jo UB, Ryu HY, et al. (2010). Histochemical study of intestinal mucins after administration of silver nanoparticles in Sprague-Dawley rats. Arch Toxicol 84:63-9.
10. Kawata K, Osawa M, Okabe S. (2009). In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol 43:6046-51.
11. Kim JA, A ° berg C, Salvati A, Dawson KA. (2012). Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol 7:62-8.
12. Kim YS, Song MY, Park JD, et al. (2010). Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol 7:20-31.
13. Loeschner K, Hadrup N, Qvortrup K, et al. (2011). Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8:18-42.
14. Martinez-Gutierrez F, Olive PL, Banuelos A, et al. (2010). Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles. Nanomed-Nanotechnol 6:681-8.
15. Nersisyan HH, Lee JH, Son HT, et al. (2003). A new and effective chemical reduction method for preparation of nanosized silver powder and colloid dispersion. Mater Res Bull 38:949-56.
16. Nikaido H, Vaara M. (1985). Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49:1-32.
17. Oberdo?rster G, Maynard A, ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group, et al. (2005). Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8.
18. Pana'cek A, Kvitek L, Prucek R, et al. (2006). Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem 110:16248-53.
19. Peters A, Wichmann HE, Tuch T, et al. (1997). Respiratory effects are associated with the number of ultrafine particles. Am J of Resp Crit Care 155:1376-83.
20. Raetz CRH. (1990). Biochemistry of endotoxins. Annu Rev of Biochem 59:129-70.
21. Richard III JW, Spencer BA, McCoy LF, et al. (2002). Acticoat versus silver ion: the truth. J Burns Wound Care (Renamed as ePlasty) 1:11-20.
22. Shrivastava S, Bera T, Roy A, et al. (2007). Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 18:225103-12.
23. Shrivastava S, Bera T, Singh SK, et al. (2009). Characterization of antiplatelet properties of silver nanoparticles. ACS Nano 3:1357-64.
24. Silva MT, Sousa JCF. (1973). Ultrastructure of the cell wall and cytoplasmic membrane of gram-negative bacteria with different fixation techniques. J Bacteriol 113:953-62.
25. Sondi I, Salopek-Sondi B. (2004). Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275:177-82.
26. Stoimenov PK, Klinger RL, Marchin GL, Klabunde KJ. (2002). Metal oxide nanoparticles as bactericidal agents. Langmuir 18:6679-86.
27. Summers HD. (2012). Nanoparticles in the life of a cell. Nat Nanotechnol 7:9-10.
28. Summers HD, Rees P, Holton MD, et al. (2011). Statistical analysis of nanoparticle closing in a dynamic cellular system. Nat Nanotechnol 6:170-4.
29. Tang J, Xiong L, Wang S, et al. (2009). Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol 9:4924-32.
30. Tang J, Xiong L, Zhou G, et al. (2010). Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro. J Nanosci Nanotechnol 10:6313-17.
31. Xing ZC, Chae WP, Huh MW, et al. (2011). In vitro anti-bacterial and cytotoxic properties of silver-containing poly(L-lactide-co-glycolide) nanofibrous scaffolds. J Nanosci Nanotechnol 11:61-5.